PAK4 and breast cancer: Nulliparous PAK4-overexpressing mice developed mammary lesions by 6 months of age that progressed into mammary tumors in 25% of the cases at 20–24 months of age.1 Importantly, exome sequencing revealed that these tumors occasionally exhibited activating RAS mutations.